| Vikki Crisco, PT, DPT | |
|
9053 Estate Thomas, St Thomas, VI 00802 | |
| (817) 874-3315 | |
| Not Available |
| Full Name | Vikki Crisco |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 9 Years |
| Location | 9053 Estate Thomas, St Thomas, Virgin Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396125563 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sportherapy Llc | 0749536308 | 45 |
News Archive
Cytos Biotechnology Ltd today announced that Novartis will discontinue the NIC002 project, which is a therapeutic vaccine candidate for the treatment of nicotine addiction.
Amylin Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2010. The Company reported total revenue of $164.4 million for the quarter ended June 30, 2010, which includes net product sales of $162.5 million. Net loss, excluding a restructuring charge of $3.4 million, was $40.8 million, or $0.28 per share.
Dexcom, Inc., a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that it has received U.S. Food and Drug Administration (FDA) approval for its CGM remote mobile communications device: Dexcom SHARE.
The National Institutes of Health has awarded $3.6 million to Rebecca Lynch, PhD, assistant professor of microbiology, immunology, and tropical medicine at the George Washington University School of Medicine and Health Sciences, to investigate HIV-1 resistance to antibody treatments.
› Verified 2 days ago
| Provider Name | Sportherapy Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1386132132 PECOS PAC ID: 0749536308 Enrollment ID: O20190724000246 |
News Archive
Cytos Biotechnology Ltd today announced that Novartis will discontinue the NIC002 project, which is a therapeutic vaccine candidate for the treatment of nicotine addiction.
Amylin Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2010. The Company reported total revenue of $164.4 million for the quarter ended June 30, 2010, which includes net product sales of $162.5 million. Net loss, excluding a restructuring charge of $3.4 million, was $40.8 million, or $0.28 per share.
Dexcom, Inc., a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that it has received U.S. Food and Drug Administration (FDA) approval for its CGM remote mobile communications device: Dexcom SHARE.
The National Institutes of Health has awarded $3.6 million to Rebecca Lynch, PhD, assistant professor of microbiology, immunology, and tropical medicine at the George Washington University School of Medicine and Health Sciences, to investigate HIV-1 resistance to antibody treatments.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vikki Crisco, PT, DPT Po Box 9196, St Thomas, VI 00801-2196 Ph: (817) 874-3315 | Vikki Crisco, PT, DPT 9053 Estate Thomas, St Thomas, VI 00802 Ph: (817) 874-3315 |
News Archive
Cytos Biotechnology Ltd today announced that Novartis will discontinue the NIC002 project, which is a therapeutic vaccine candidate for the treatment of nicotine addiction.
Amylin Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2010. The Company reported total revenue of $164.4 million for the quarter ended June 30, 2010, which includes net product sales of $162.5 million. Net loss, excluding a restructuring charge of $3.4 million, was $40.8 million, or $0.28 per share.
Dexcom, Inc., a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that it has received U.S. Food and Drug Administration (FDA) approval for its CGM remote mobile communications device: Dexcom SHARE.
The National Institutes of Health has awarded $3.6 million to Rebecca Lynch, PhD, assistant professor of microbiology, immunology, and tropical medicine at the George Washington University School of Medicine and Health Sciences, to investigate HIV-1 resistance to antibody treatments.
› Verified 2 days ago
Dr. Nkinzo M. Nkunzi, DRPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1902 9th St, Unit 1, #341 Pmb Nisky Center, St Thomas, VI 00802 Phone: 340-776-0899 | |
Bonnie J O'rourke-barr, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 6115 Estate Smith Bay Apt 5, Suite 334, 335, St Thomas, VI 00802 Phone: 340-513-9166 | |
Mr. Daniel John Sims, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 9149 Estate Thomas, Suite 104, Paragon Medical Building, St Thomas, VI 00802 Phone: 340-714-2845 | |
Horizon Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 9154 Estate Thomas, M.m. Electric Building Lower Level, St Thomas, VI 00802 Phone: 340-776-7667 Fax: 340-714-1891 | |
Christopher Ryan Wilson, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 9149 Estate Thomas, Paragon Medical Bldg Ste 104, St Thomas, VI 00802 Phone: 340-714-2845 Fax: 340-714-2843 | |
Total Rehab & Wellness Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5302 Yacht Haven Grande, Suite S-100, St Thomas, VI 00802 Phone: 340-776-7342 | |
Therapy Works, Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 1001 Estate Ross Ste 6, St Thomas, VI 00802 Phone: 340-779-4678 Fax: 340-715-4678 |